story of the week
ABT-450/r–Ombitasvir and Dasabuvir With Ribavirin for HCV Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- ABT-450/r–Ombitasvir and Dasabuvir With Ribavirin for HCV With Cirrhosis
- Costs of Hepatitis C Therapy Options
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- ABT-450/r–Ombitasvir and Dasabuvir With Ribavirin for HCV Retreatment
- Treatment Strategies for Hepatitis C
- FDA Approves First Combination Pill to Treat Hepatitis C
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine